Understanding the causes and treatments of recurrent acute pancreatitis
Official title: Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis: a Prospective Cohort Study
Run by Changhai Hospital · NCT06355206 · Data updated 2026-11-12
This study is trying to find out what causes recurrent acute pancreatitis and whether treatments like endoscopy, surgery, or conservative care can help prevent it from coming back.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Changhai Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | April 22, 2024 |
| Main results expected | December 2034 |
| Study ends | December 2034 |
| Registry record updated | May 9, 2024 |
| Trial ID | NCT06355206 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with recurrent acute pancreatitis.
✕Probably not a fit
Patients who are unwilling or unable to provide consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to investigate the etiology, natural progression, and therapeutic effects of recurrent acute pancreatitis (RAP). It will assess whether endoscopic intervention, surgery, or conservative treatment can reduce the recurrence of acute pancreatitis and identify risk factors associated with its recurrence. Patients will be closely monitored, and their clinical information will be systematically recorded to provide insights into the condition's management and outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients suffering from recurrent acute pancreatitis.
How similar studies have gone: While there have been studies on acute pancreatitis, this specific observational approach focusing on recurrent cases and treatment efficacy is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with recurrent acute pancreatitis. Exclusion Criteria: * Unwilling or unable to provide consent.
Where it's running
-
Changhai Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Lianghao Hu, M.D.
- Email: lianghao-hu@smmu.edu.cn
- Phone: +86-13817593520
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Soy-tomato juice for people with recurrent acute or chronic pancreatitis
This will try giving daily soy-tomato juice to people with recurrent acute or chronic pancreatitis to see if they can tolerate it and whether it reduces inflammation and symptoms.
-
Blood test to find mild-to-moderate pancreatic enzyme insufficiency and guide enzyme treatment for people with pancreatitis
This project will use the Malabsorption Blood Test to find adults with recurrent acute or chronic pancreatitis who have mild-to-moderate exocrine pancreatic insufficiency and see if pancreatic enzyme replacement for responsive patients improves quality of life.
-
Biologic treatment for adults with ABPA and severe asthma
This project will test whether biologic medicines help adults with ABPA who have severe asthma and elevated eosinophils.
-
Respiratory infections in newborns and children up to five years
This project will follow newborns in Colombia and Panamá through age five to see how often respiratory infections happen, which germs cause them, and how those infections affect long-term lung health.
-
Radiofrequency ablation for severe leg vein disease in people 80 and older
This will try radiofrequency ablation in people aged 80 and older with severe chronic venous insufficiency to see if it safely closes the leaking saphenous veins and improves symptoms and quality of life.
-
Tianshan community long-term health follow-up
This program will follow adults in northwest China using annual health exams and electronic records to see how health and disease change over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.